• Update on cytomegalovirus infections – final recommendations
• Update on antifungal prophylaxis – final recommendations
• Clostridioides difficile infections in patients with hematological malignancies - final recommendations
• Update on COVID-19 and respiratory infections
  • Update on COVID- 19
  • Update on CARV (coming soon)
• Bacterial: new drugs - duration of therapy - febrile neutropenia

ECIL 9 Part 2 - Revised Guidelines

• Update on Hepatitis B, C and E - revised guidelines
• Toxoplasmosis/Toxoplasma infection and disease - final recommendations (pdf file)
• Update on fungal diagnostics - revised guidelines
• Update on COVID 19 in Hematology-Oncology patients:
  • Epidemiology and risk factors - final recommendations (pdf file)
  • Viral biology and diagnosis - revised guidelines
  • Clinical symptoms and Infection control -  final recommendations (pdf file)
  • Therapy - final recommendations (pdf file)
  • Vaccine - final recommendations (pdf file)

List of ECIL 9 on-site attendees

Download the final recommendations of the two first groups of ECIL 9

Covid19 in Hemathology-Oncology patients

• Epidemiology and risk factors - final recommendations (pdf file)
• Viral biology and diagnosis - final recommendations (pdf file)
• Clinical symptoms and Infection control - final recommendations (pdf file)
• Therapy - final recommendations (pdf file)
• Vaccine - final recommendations (pdf file)

Infections in AML and ALL patients treated with new molecules and antibodies - final recommendations (pdf file)

List of ECIL 9 online attendees

Previous Conference

ECIL 8 (2019)

Download the final recommendations of each group of ECIL 8

• Update on Fungal and Bacterial Infections Group - (pediatric febrile neutropenia) - final slide set
  
• Update on Fungal and Bacterial Infections Group - (pediatric antifungal guidelines) - final slide set
  
• Tuberculosis and atypical mycobacterial infections - final slide set
  
• Update on Community-acquired respiratory viruses in hematology patients - final slide set

List of ECIL 8 attendees

ECIL 7 (2017)

Download the final recommendations of each group of ECIL 7

• CMV infection - final slide set
• HHV6 infection - final slide set
• Vaccines in non-HSCT patients with hematological malignancies - final slide set
• Management of infection in hematology patients receiving new drugs and biotherapies - final slide set

ECIL 6 (2015)

Download the final recommendations of each group of ECIL 6

• Aspergillus guidelines: to a consensus of ECIL and ESCMID
• BK virus infection in HSCT recipients - final slide set
• EBV in HSCT: update of ECIL guidelines - final slide set
• TDM of antifungal drugs - final slide set
• Pneumocystis pneumonia treatment - final slide set
• Antibacterial prophylaxis: critical appraisal of previous ECIL guidelines - final slide set

ECIL 5 (2013)

Download the final recommendations of each group of ECIL 5

• Management of viral hepatitis in hematology patients - final slide set
• Pneumocystic jirovecii infections in (non HIV-infected) hematology patients : biological aspects - final slide set
• Pneumocystic jirovecii infections in (non HIV-infected) hematology patients : Clinical aspects - final slide set
• Primary Antifungal Prophylaxis - final slide set
• Antifungal Therapy in Leukemia and HSCT Patients - final slide set

ECIL 4 (2011)

Download the final recommendations of each group of ECIL 4

• Management of adenovirus (ADV) infections - final slide set
• Management of respiratory virus infections 2
  • Influenza Virus - final slide set
  • Other Viruses - final slide set
• Update of previous fungal and viral guidelines
  • EBV management in patients with leukemia and other hematological disorders - final slide set
  • CMV and HHV-6 management in patients with hematological diseases - final slide set
  • Antifungal therapy - final slide set
• Bacterial resistance in hematology ward, implication for clinical practice - final slide set
• Specific considerations of fungal desease and antifungal treatment in children - final slide set

ECIL 3 (2009)

Download the final recommendations of each group of ECIL 3

• Empirical Antifungal therapy - final slide set
• Antifungal prophylaxis - final slide set
• Antifungal treatment of Aspergillus and Candida infections - final slide set
• Management of herpes virus infections
  • CMV, HHV6 - final slide set
  • EBV - final slide set
• Zygomycosis - final slide set
• Classical diagnostic procedures of IFI
• Non-ivasive diagnostic procedures for Aspergillus - final slide set
• Non-ivasive diagnostic procedures for yeasts - final slide set
• Béta-D glucane - final slide set

ECIL 2 (2007)

Download the final recommendations of each group of ECIL 2

• Empirical Antifungals therapy - final slide set
• Antifungal prophylaxix - final slide set
• Antifungal treatment of Aspergillus and Candida infections - final slide set
• Management of herpes virus infections
  • HSV - final slide set
  • VZV - final slide set
  • CMV, HHV-6,7,8 - final slide set
  • EBV - final slide set
• Management of other viral infections
  • Respiratory Viruses, Influenza Virus
  • Polyoma, Parainfluenza virus

ECIL 1 (2005)

Download the final recommendations of each group of ECIL 1

• Fluoroquinolone prophylaxis in neutropenic patients - final slide set
• Aminoglycosides in febrile neutropenia - final slide set
• Glycopeptides and other antiGram+ antibiotics in febrile neutropenia - final slide set
• Empirical antifungal treatment for persistent fever in neutropenic patients - final slide set
• Antifungal prophylaxis - final slide set
• Antifungal therapy  - final slide set